Main Article Content
Diabetic neuropathy (DN) is microvascular complication associated with type 2 diabetes mellitus. The incidences of DN have increased with leaps and bounds due to increased prevalence of hyperglycemia. Common pathways underlie obesity, diabetes and gait; such as oxidative stress in mitochondrial dysfunction and inflammations. Obesity, disturb gait pattern, inadequate control of posture, high pressure on lower extremities and decrease in amount of bone mineral density, leads to increased incidences of bone fractures and injuries that show critical links with diabetic neuropathy. Obesity causes alterations in autonomic nervous system with prompt imbalances in sympathetic-parasympathetic activity, while alterations in the sensory-somatic nervous system may cause peripheral polyneuropathy which is a general complication in diabetic obese patients. Gait is a series of movements that shows propulsion of human skeleton, from heel-strike to heel-strike. Gait functions and balance are impaired in many of the neural disorders in which DN is the most common. DN includes a focal and multifocal neuropathy, sensorimotor polyneuropathy etc, which attributes to metabolic and micro-vessel changes caused by hyperglycemia and obesity like complication, resulting in muscle weakness and nerve pain. So many drugs are also available in market such as pregabalin, gabapentin, etc that invade the painful neuropathic pain but failed to treat the abnormal gait. Evidence on the effectiveness of conventional interventions for restoration of balance is limited in case diabetic neuropathy. This review discusses the link between obesity, diabetic neuropathy and gait abnormalities.
Kitada M, Zhang Z, Mima A, King GL. Molecular mechanisms of diabetic vascular complications. Journal of Diabetes Investigation. 2010;1(3):77-89.
Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK, Adhikari P, Rao PV, Saboo B, Kumar A, Bhansali A. Prevalence of diabetes and prediabetes in 15 states of India: Results from the ICMR–INDIAB population-based cross-sectional study. The Lancet Diabetes & Endocrinology. 2017;5(8):585-596.
Alport AR, Sander HW. Clinical approach to peripheral neuropathy: Anatomic localization and diagnostic testing. CONTINUUM: Lifelong Learning in Neurology. 2012;18(1): 13-38.
Global Journals Inc. (USA). Diseases type: Double blind peer reviewed international research journal. Global Journal of Medical Research. 2016;16(5):Versions 1.0.
American Diabetes Association. American Diabetes Association: Standards of medical care in diabetes (position statement). Diabetes Care. 2011;34(Suppl 1):S11-61.
Iqbal Z, Azmi S, Yadav R, Ferdousi M, Kumar M, Cuthbertson DJ, Lim J, Malik RA, Alam U. Diabetic peripheral neuropathy: Epidemiology, diagnosis and pharmacotherapy. Clinical Therapeutics. 2018;40(6):828-849.
Kuo AD, Donelan JM. Dynamic principles of gait and their clinical implications. Physical Therapy. 2010;90(2):157-174.
Nutt JG, Marsden CD, Thompson PD. Human walking and higher‐level gait disorders, particularly in the elderly. Neurology. 1993;43(2):268-268.
Callaghan BC, Gao L, Li Y, Zhou X, Reynolds E, Banerjee M, Pop‐Busui R, Feldman EL, Ji L. Diabetes and obesity are the main metabolic drivers of peripheral neuropathy. Annals of Clinical and Translational Neurology. 2018;5(4):397-405.
Smith AG, Singleton JR. Obesity and hyperlipidemia are risk factors for early diabetic neuropathy. Journal of Diabetes and Its Complications. 2013;27(5):436-442.
Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes and Alzheimer's disease. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 2017;1863(5):1037-1045.
Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Reviews in Endocrine and Metabolic Disorders. 2014;15(4):277-87.
Lerner ZF, Board WJ, Browning RC. Effects of obesity on lower extremity muscle function during walking at two speeds. Gait & Posture. 2014;39(3):978-984.
Ziegler D, Rathmann W, Dickhaus T, Meisinger C, Mielck A. Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: The MONICA/KORA Augsburg Surveys S2 and S3. Diabetes Care. 2008;31(3):464-469.
Brach JS, Talkowski JB, Strotmeyer ES, Newman AB. Diabetes mellitus and gait dysfunction: Possible explanatory factors. Physical Therapy. 2008;88(11):1365-74.
Alfuth M, Rosenbaum D. Effects of changes in plantar sensory feedback on human gait characteristics: A systematic review. Footwear Science. 2012;4(1):1-22.
Deforche BI, Hills AP, Worringham CJ, Davies PS, Murphy AJ, Bouckaert JJ, De Bourdeaudhuij IM. Balance and postural skills in normal-weight and overweight prepubertal boys. International Journal of Pediatric Obesity. 2009;4(3):175-182.
Tsiros MD, Coates AM, Howe PR, Grimshaw PN, Walkley J, Shield A, Mallows R, Hills AP, Kagawa M, Shultz S, Buckley JD. Knee extensor strength differences in obese and healthy-weight 10-to 13-year-olds. European Journal of Applied Physiology. 2013;113(6): 1415-1422.
D’Hondt E, Deforche B, De Bourdeaudhuij I, Lenoir M. Childhood obesity affects fine motor skill performance under different postural constraints. Neuroscience Letters. 2008;440(1): 72-75. DOI:https://doi.org/10.1016/j.neulet.2008.05.056
Pop-Busui R, Boulton AJ, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic neuropathy: A position statement by the American Diabetes Association. Diabetes Care. 2017;40(1):136-154.
Winter DA. Biomechanics of normal and pathological gait: Implications for understanding human locomotor control. Journal of Motor Behavior. 1989;21(4):337-355. DOI:https://doi.org/10.1080/00222895.1989.10735488
Whittle MW. Clinical gait analysis: A review. Human Movement Science. 1996;15(3):369-387.
Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes. 2005;54(6):1615-1625.
Hozumi J, Sumitani M, Matsubayashi Y, Abe H, Oshima Y, Chikuda H, Takeshita K, Yamada Y. Relationship between neuropathic pain and obesity. Pain Research and Management; 2016.
Menz HB, Lord SR, St George R, Fitzpatrick RC. Walking stability and sensorimotor function in older people with diabetic peripheral neuropathy. Archives of Physical Medicine and Rehabilitation. 2004;85(2):245-252.
Yan SH, Zhang K, Tan GQ, Yang J, Liu ZC. Effects of obesity on dynamic plantar pressure distribution in Chinese prepubescent children during walking. Gait & Posture. 2013;37(1):37-42.
Blake AJ, Morgan K, Bendall MJ, Dallosso H, Ebrahim SB, Arie TA, Fentem PH, Bassey EJ. Falls by elderly people at home: Prevalence and associated factors. Age and Ageing. 1988;17(6):365-372.
Vinik AI, Bril V, Kempler P, Litchy WJ, Tesfaye S, Price KL, Bastyr III EJ, MBBQ Study Group. Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C β-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial. Clinical Therapeutics. 2005;27(8):1164-80.
Petrofsky J, Lee S, Macnider M, Navarro E. Autonomic, endothelial function and the analysis of gait in patients with type 1 and type 2 diabetes. Acta Diabetologica. 2005;42(1):7-15.
Lalli P, Chan A, Garven A, Midha N, Chan C, Brady S, Block E, Hu B, Toth C. Increased gait variability in diabetes mellitus patients with neuropathic pain. Journal of Diabetes and Its Complications. 2013;27(3):248-254.
Karmakar S, Rashidian H, Chan C, Liu C, Toth C. Investigating the role of neuropathic pain relief in decreasing gait variability in diabetes mellitus patients with neuropathic pain: A randomized, double-blind crossover trial. Journal of Neuroengineering and Rehabilitation. 2014;11(1):125.
Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998;21(10):1714-9.
Fernando M, Crowther R, Lazzarini P, Sangla K, Cunningham M, Buttner P, Golledge J. Biomechanical characteristics of peripheral diabetic neuropathy: A systematic review and meta-analysis of findings from the gait cycle, muscle activity and dynamic barefoot plantar pressure. Clinical Biomechanics. 2013;28(8): 831-845. DOI:https://doi.org/10.1016/j.clinbiomech.2013.08.004
Mustapa A, Justine M, Mustafah NM, Manaf H. The effect of diabetic peripheral neuropathy on ground reaction forces during straight walking in stroke survivors. Rehabilitation Research and Practice; 2017.
Hazari A, Maiya AG, Shivashankara KN, Agouris I, Monteiro A, Jadhav R, Kumar S, Kumar CS, Mayya SS. Kinetics and kinematics of diabetic foot in type 2 diabetes mellitus with and without peripheral neuropathy: A systematic review and meta-analysis. Springer Plus. 2016;5(1):18-19.
Turner DE, Helliwell PS, Burton AK, Woodburn J. The relationship between passive range of motion and range of motion during gait and plantar pressure measurements. Diabetic Medicine. 2007;24(11):1240-6.
Jang HC. Sarcopenia, frailty, and diabetes in older adults. Diabetes & Metabolism Journal. 2016;40(3):182-189.
Andreassen CS, Jakobsen J, Ringgaard S, Ejskjaer N, Andersen H. Accelerated atrophy of lower leg and foot muscles—a follow-up study of long-term diabetic polyneuropathy using magnetic resonance imaging (MRI). Diabetologia. 2009;52(6):1182-91.
Almurdhi MM, Reeves ND, Bowling FL, Boulton AJ, Jeziorska M, Malik RA. Reduced lower-limb muscle strength and volume in patients with type 2 diabetes in relation to neuropathy, intramuscular fat, and vitamin D levels. Diabetes Care. 2016;39(3):441-447.
Allen MD, Major B, Kimpinski K, Doherty TJ, Rice CL. Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy. Journal of Applied Physiology. 2013;116(5):545-552.
Nouman M, Chatpun S, Prachgosin T, Leelasamran W. Plantar pressure distribution in non-obese, overweight and obese subjects with diabetic neuropathy while walking. In 2018 11th Biomedical Engineering International Conference (BMEiCON). IEEE. 2018;1-4.
Butterworth PA, Urquhart DM, Landorf KB, Wluka AE, Cicuttini FM, Menz HB. Foot posture, range of motion and plantar pressure characteristics in obese and non-obese individuals. Gait & Posture. 2015;41(2):465-9.
Chantelau E, Onvlee GJ. Charcot foot in diabetes: Farewell to the neurotrophic theory. Hormone and Metabolic Research. 2006;38(06):361-7.
Uccioli L, Sinistro A, Almerighi C, Ciaprini C, Cavazza A, Giurato L, Ruotolo V, Spasaro F, Vainieri E, Rocchi G, Bergamini A. Proinflammatory modulation of the surface and cytokine phenotype of monocytes in patients with acute Charcot foot. Diabetes Care. 2010;33(2):350-5.
Wukich DK, Raspovic KM, Hobizal KB, Sadoskas D. Surgical management of Charcot neuroarthropathy of the ankle and hindfoot in patients with diabetes. Diabetes/Metabolism Research and Reviews. 2016;32:292-296.
Bus SA, Valk GD, Van Deursen RW, Armstrong DG, Caravaggi C, Hlaváček P, Bakker K, Cavanagh PR. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: A systematic review. Diabetes/Metabolism Research and Reviews. 2008;24(S1):S162-80.
Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M. Gait speed and survival in older adults. JAMA. 2011;305(1):50-8.
Allet L, Armand S, De Bie RA, Golay A, Monnin D, Aminian K, Staal JB, de Bruin ED. The gait and balance of patients with diabetes can be improved: A randomised controlled trial. Diabetologia. 2010;53(3):458-466.
De Mettelinge TR, Delbaere K, Calders P, Gysel T, Van Den Noortgate N, Cambier D. The impact of peripheral neuropathy and cognitive decrements on gait in older adults with type 2 diabetes mellitus. Archives of Physical Medicine and Rehabilitation. 2013;94(6):1074-9.
Yi LC, Sartor CD, Souza FT, Sacco IC. Intralimb coordination patterns in absent, mild, and severe stages of diabetic neuropathy: looking beyond kinematic analysis of gait cycle. PloS one. 2016;11(1):e0147300.
Shah C. Effects of sensory training over two different surfaces on balance and gait in persons with diabetic neuropathy. International Journal of Recent Scientific Research. 2016;7(3):9285-9290.
Hamatani M, Mori T, Oe M, Noguchi H, Takehara K, Amemiya A, Ohashi Y, Ueki K, Kadowaki T, Sanada H. Factors associated with callus in patients with diabetes, focused on plantar shear stress during gait. Journal of Diabetes Science and Technology. 2016;10(6): 1353-1359.
Najafi B, Talal TK, Grewal GS, Menzies R, Armstrong DG, Lavery LA. Using plantar electrical stimulation to improve postural balance and plantar sensation among patients with diabetic peripheral neuropathy: A randomized double blinded study. Journal of Diabetes Science and Technology. 2017;11(4): 693-701.
Dias LS, Nienov OH, Goelzer Neto CF, Schmid H. Unsteady walking as a symptom in type 2 diabetes mellitus: Independent association with depression and sedentary lifestyle and no association with diabetic neuropathy. Brazilian Journal of Medical and Biological Research. 2018;51(5).
Esser P, Collett J, Maynard K, Steins D, Hillier A, Buckingham J, Tan GD, King L, Dawes H. Single sensor gait analysis to detect diabetic peripheral neuropathy: A proof of principle study. Diabetes & Metabolism Journal. 2018;42(1):82-6.
Chong MS, Hester J. Diabetic painful neuropathy. Drugs. 2007;67(4):569-585.
Watson JC, Dyck PJ. Peripheral neuropathy: A practical approach to diagnosis and symptom management. InMayo Clinic Proceedings. Elsevier. 2015;90(7):940-951.
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2012;12.
Schwartz S, Etropolski M, Shapiro DY, Okamoto A, Lange R, Haeussler J, Rauschkolb C. Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: Results of a randomized-withdrawal, placebo-controlled trial. Current Medical Research and Opinion. 2011;27(1): 151-162. DOI:https://doi.org/10.1185/03007995.2010.537589
Raffa RB, Friderichs EL, Reimann WO, Shank RP, Codd EE, Vaught JL. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. Journal of Pharmacology and Experimental Therapeutics. 1992;260(1):275-285.
Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Canadian Journal of Anesthesia. 2000;47(6):585.
Mihic S, Harris R. Alcohol health res world. GABA and the GABAA Receptor. 1997;21: 127-131.
Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E, Gabapentin Diabetic Neuropathy Study Group. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA. 1998;280(21):1831- 6.
Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, Garg P. Sodium valproate for painful diabetic neuropathy: A randomized double-blind placebo-controlled study. QJM. 2004;97(1):33-38.
Wiffen PJ, Derry S, Moore RA, Kalso EA. Carbamazepine for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews. 2014;4.
Curia G, Biagini G, Perucca E, Avoli M. Lacosamide. CNS Drugs. 2009;23(7):555-568.
Cohen K, Shinkazh N, Frank J, Israel I, Fellner C. Pharmacological treatment of diabetic peripheral neuropathy. Pharmacy and Therapeutics. 2015;40(6):372.
Zhou M, Chen N, He L, Yang M, Zhu C, Wu F. Oxcarbazepine for neuropathic pain. Cochrane Database of Systematic Reviews. 2017;12.
Javed S, Petropoulos IN, Alam U, Malik RA. Treatment of painful diabetic neuropathy. Therapeutic Advances in Chronic Disease. 2015;6(1):15-28.
Cheung CW, Ching Wong SS, Qiu Q, Wang X. Oral oxycodone for acute postoperative pain: A review of clinical trials. Pain Physician. 2017;20(2S):SE33-52.
Ye W, Zhao Y, Robinson RL, Swindle RW. Treatment patterns associated with Duloxetine and Venlafaxine use for major depressive disorder. BMC Psychiatry. 2011;11(1):19.
Amagai Y, Tanaka A, Matsuda A, Oida K, Jung K, Nishikawa S, Jang H, Ishizaka S, Matsuda H. Topical application of ketoprofen improves gait disturbance in rat models of acute inflammation. BioMed Research International; 2013.
Kakkar AK, Dahiya N. Drug treatment of obesity: Current status and future prospects. European Journal of Internal Medicine. 2015;26(2):89-94.
Gokcel A, Gumurdulu Y, Karakose H, Melek Ertorer E, Tanaci N, Bascil Tutuncu N, Guvener N. Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity. Diabetes, Obesity and Metabolism. 2002;4(1):49-55.
Smith SR, Blundell JE, Burns C, Ellero C, Schroeder BE, Kesty NC, Chen KS, Halseth AE, Lush CW, Weyer C. Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: A 6-wk translational research study. American Journal of Physiology-Endocrinology and Metabolism. 2007;293(2):E620-7.
Van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. International Journal of Obesity. 2014;38(6): 784.
Taveggia G, Villafañe JH, Vavassori F, Lecchi C, Borboni A, Negrini S. Multimodal treatment of distal sensorimotor polyneuropathy in diabetic patients: A randomized clinical trial. Journal of Manipulative and Physiological Therapeutics. 2014;37(4):242-252.
Morrison S, Colberg SR, Mariano M, Parson HK, Vinik AI. Balance training reduces falls risk in older individuals with type 2 diabetes. Diabetes Care. 2010;33(4):748-750.
Van Netten JJ, Price PE, Lavery LA, Monteiro‐Soares M, Rasmussen A, Jubiz Y, Bus SA, International Working Group on the Diabetic Foot (IWGDF). Prevention of foot ulcers in the at‐risk patient with diabetes: A systematic review. Diabetes/Metabolism Research and Reviews. 2016;32:84-98.
Van Deursen R. Mechanical loading and off-loading of the plantar surface of the diabetic foot. Clinical Infectious Diseases. 2004;39(Supplement_2):S87-91.
Plummer P, Apple S, Dowd C, Keith E. Texting and walking: Effect of environmental setting and task prioritization on dual-task interference in healthy young adults. Gait & Posture. 2015;41(1):46-51.